ResMed, Google ’ s Verily ink sleep-apnea-focused joint venture deal
ResMed (NYSE:RMD) and Google (NSDQ:GOOG) life sciences company Verily said today they inked a new joint venture deal aiming to develop software solutions to improve diagnosis, treatment and care for sleep apnea and other breathing related sleep disorders. The new US-based joint venture will use sleep apnea knowledge from San Diego-based ResMed and Verily’s data analytics technologies in its pursuits, the companies said, and will operate as a separate venture from both ResMed and Verily. “The vast majority of people with sleep apnea don’t realize they have it, and therefore don’t seek accessible, effective treatment to mitigate its effects and long-term health risks. The combined industry expertise, scalable infrastructure, and data analytics capabilities of ResMed and Verily can unlock meaningful ways to identify these individuals and support their journey to improved sleep, health and quality of life,” ResMed chief medical officer Dr. Carlos Nunez said in a prepared statement. “Approaching a widespread health problem like sleep apnea through collecting, organizing and activating health data is central to Verily’s mission. By better identifying at-risk individuals as well as generating real-world evidence regarding the value and effectiveness of treatment, this collaboration has the potential to improve outcomes for millions of people living with sleep apnea, and potentially other related conditions,” Verily ...
(Oregon Health&Science University) Patients with sleep apnea who have short interruptions in breathing while they sleep are at higher risk for death than those with longer interruptions, according to a study published in the American Journal of Respiratory and Critical Care Medicine. The finding could help doctors better prevent long-term mortality associated with obstructive sleep apnea.
The device senses blood oxygenation, heart rate, sleep position, and stopped breathing events.
Resumo A apneia obstrutiva do sono (AOS) é um dos distúrbios do sono mais frequentes, associada ao risco aumentado para obesidade, hipertensão e evento cardiovascular. O presente estudo buscou investigar a prevalência da AOS em trabalhadores de turno. Foi realizada a revisão sistemática da literatura, utilizando-se os descritores “ sleep apnea ” AND “ shift work ” , nas bases de dados do PubMed Central, Biblioteca Virtual em Sa úde, Web of Science e Scopus, incluindo-se artigos que apresentaram a frequência da AOS em trabalhadores de turno, publi...
Abstract PURPOSE: Obstructive sleep apnea and chronic obstructive pulmonary disease are independent risk factors of cardiovascular disease (CVD), and their coexistence is known as overlap syndrome (OS). Endothelial dysfunction is the initial stage of CVD; however, underlying mechanisms linking OS and CVD are not well understood. The aim of this study was to explore whether OS can lead to more severe inflammation and endothelial apoptosis by promoting endothelial dysfunction, and to assess the intervention effects of antioxidant tempol. MATERIALS AND METHODS: Male Wistar rats (n=66) were exposed to normal oxyg...
ConclusionsThis study gives new insights into the changes in distribution of collapse patterns when passive maneuvers are applied during DISE. Jaw thrust and lateral head rotation gave improvement of obstruction mostly in line with previous research. The CNCC and CCC groups responded similarly to application of a single maneuver, but there was a significant difference found when both maneuvers were combined.
The increasing prevalence of overweight or obese children and adolescents is a significant global health concern. While the effect of obesity on cardiovascular function has been investigated, little is known on the impact of associated obstructive sleep apnea (OSA) in obese youth. The aim of the current study was to investigate the influence of OSA on cardiovascular functional parameters in obese youth. This is a prospective single-center observational cross-sectional study. Forty-four obese patients and 44 age and gender matched control subjects were included.
ConclusionWe failed to confirm previously reported associations between the majority of the studied polymorphisms and sleep apnea. Body weight seems to be an important cofounding factor that needs to be accounted for, when genetic association studies are performed for sleep apnea.
CONCLUSIONS: Proper selection of primary treatment to manage patients with OSA was possible under one-roof system that included dental sleep medicine. PMID: 30319005 [PubMed - in process]
Conclusions: PAP dispensation for sleep apnea did not appear to reduce the rate of acute care and medication utilization over several years of follow-up in a large integrated health care system.
This guideline provides evidence-based recommendations regarding the intraoperative care of adults with obstructive sleep apnea.Anesthesia &Analgesia